Foeldvari, Ivan <br/><br/>
High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.  [electronic resource] 

 -  The Journal of rheumatology  May 2002 
 - 1079-83 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0315-162X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Arthritis, Juvenile--drug therapy<br/>Child<br/>Child, Preschool<br/>Cyclooxygenase 1<br/>Cyclooxygenase 2<br/>Cyclooxygenase 2 Inhibitors<br/>Cyclooxygenase Inhibitors--administration & dosage<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Isoenzymes--antagonists & inhibitors<br/>Male<br/>Meloxicam<br/>Membrane Proteins<br/>Patient Satisfaction<br/>Prostaglandin-Endoperoxide Synthases<br/>Thiazines--administration & dosage<br/>Thiazoles--administration & dosage<br/>Treatment Outcome